Clinical Trial: Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07851337) titled 'Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy' on Sept. 01.

Brief Summary: The purpose of this trial is to evaluate the immunomodulatory effects of glatiramer acetate (GA) in improving the recovery of CD4 T cells and the CD4/CD8 ratio in people living with HIV (PLWHIV) who have poor immune recovery and persistent immune activation, despite virologically effective antiretroviral (ARV) treatment.

ANRS 0766s GEODE is a Pilot, multicenter, randomised and open-label clinical trial:

Participants will be randomized 2:1 to either one of the two parallel arms

* Arm A (24 particip...